RxDoctor Payments Data

Charles Barker, DO

Family Medicine · Belding, MINPI 1588612576

Payments from drug & device makers

$6,351in general payments, 2019–2025

Across 384 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$937
  • AbbVie$569
  • AstraZeneca$539
  • Lilly USA, LLC$355
  • Pfizer$353
  • Boehringer Ingelheim$341
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$6,331100%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,351 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$684
Medicare patients
42
Services billed
88

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prolastin CAlpha-1-Proteinase Inhibitor11$68,518
JardianceEmpagliflozin80$62,523
EliquisApixaban56$56,643
OzempicSemaglutide26$52,795
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60$43,079
TrulicityDulaglutide23$38,564
Breztri AerosphereBudesonide/Glycopyr/Formoterol42$38,013
MounjaroTirzepatide26$28,765
FarxigaDapagliflozin Propanediol19$27,023
JanumetSitagliptin Phos/Metformin Hcl11$17,057
JanuviaSitagliptin Phosphate15$15,662
Combivent RespimatIpratropium/Albuterol Sulfate15$14,192
Lantus SolostarInsulin Glargine,hum.Rec.Anlog49$9,343
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen357$7,058
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$5,969

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat$341$76,71595 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$539$70,63672 claims
Grifols USA, LLCProlastin C$96$68,51811 claims
Lilly USA, LLCTrulicity, Mounjaro$355$67,32949 claims
PfizerEliquis$353$56,64356 claims
Novo NordiskOzempic$937$52,79526 claims
GSKTrelegy Ellipta, Breo Ellipta$336$48,68074 claims
MerckJanumet, Januvia, Belsomra$148$37,76838 claims
AbbVieSynthroid$569$1,54412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Belding

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →